Dow Jones Newswire stories by Peter Loftus covering Merck's business setbacks and Biogen's dangerous nondisclosure policy.
See the contest questionnaire in which the reporter writes about how this story was written.
Dow Jones Newswire stories by Peter Loftus covering Merck's business setbacks and Biogen's dangerous nondisclosure policy.
See the contest questionnaire in which the reporter writes about how this story was written.